Clinical development of CAR T cell therapy in China: 2020 update

Chimeric antigen receptor (CAR) T-cell therapy has achieved significant success in the treatment of hematological malignancies. In recent years, fast-growing CAR T clinical trials have actively explored their potential application scenarios. According to the data from the clinicaltrials.gov website,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jianshu, Guo, Yelei, Wang, Yao, Wu, Zhiqiang, Bo, Jian, Zhang, Bin, Zhu, Jun, Han, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115146/
https://www.ncbi.nlm.nih.gov/pubmed/32999455
http://dx.doi.org/10.1038/s41423-020-00555-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115146/
https://www.ncbi.nlm.nih.gov/pubmed/32999455
http://dx.doi.org/10.1038/s41423-020-00555-x

Ejemplares similares